Novartis Investigative Site is a clinical research site located in Louisville, Kentucky, United States 40217.
Crixeo Clinical Trials Trust Score: 27/100 (FAILING). This profile has not yet been claimed by the site owner.
Novartis Investigative Site has participated in 59 clinical trials with 1 currently active.
Therapeutic areas: Chronic Plaque-type Psoriasis, Relapsing Multiple Sclerosis, Atopic Dermatitis.
Sponsors: Novartis Pharmaceuticals, Novartis, pharmaand GmbH.
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in Kentucky · View every site in Louisville
Trust Score: 27/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Novartis Investigative Site has a Crixeo Trust Score of 27/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Novartis Investigative Site has 59 clinical trials on record, with 1 currently active. Their work covers Chronic Plaque-type Psoriasis, Relapsing Multiple Sclerosis, Atopic Dermatitis.
Novartis Investigative Site has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.